Author details

Full Name

Catherine J Wu

Affiliation

ORCID

Career Start Year

1991

Papers

250

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38057668	Dictionary of immune responses to cytokines at single-cell resolution.	Nature	2024
36595453	Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells.	Blood Adv	2023
36095842	The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia.	Blood	2023
36287248	A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.	Blood Adv	2023
36332187	Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naÃ¯ve settings.	Blood	2023
35358998	The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia.	Blood Adv	2023
37938768	Latent human herpesvirus 6 is reactivated in CAR T cells.	Nature	2023
37662211	Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons.		2023
38014338	DIISCO: A Bayesian framework for inferring dynamic intercellular interactions from time-series single-cell data.		2023
37738974	ZNF683 marks a CD8<sup>+</sup> TÂ cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.	Cancer Cell	2023
37819236	The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.		2023
37653227	Author Correction: Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling.	Nat Biotechnol	2023
37729058	Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.		2023
38093010	Slide-tags enables single-nucleus barcoding for multimodal spatial genomics.		2023
37961528	A multidimensional analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in the bone marrow of pediatric acute myeloid leukemia.		2023
37683037	Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.	Sci Immunol	2023
37156098	Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD.	Blood Adv	2023
36719743	YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma.		2023
37216223	Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse.	Blood Adv	2023
37463047	SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation.	J Clin Invest	2023
36706355	Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.	Blood	2023
36948504	Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naÃ¯ve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).		2023
36758208	Richter syndrome: novel insights into the biology of transformation.		2023
37450351	Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.	Cancer Res	2023
36477552	Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models.		2023
36624313	Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.	Nat Med	2023
37053197	Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors.	Clin Cancer Res	2023
36469010	Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models.	Cancer Research	2023
36468984	In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.	Blood Cancer Discov	2023
37430060	ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.	Nat Cancer	2023
36735774	Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.	Sci Immunol	2023
37428863	Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia.		2023
37046001	Dynamics and specificities of T cells in cancer immunotherapy.		2023
37505099	IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.	Blood Adv	2023
36720856	Enhancing CAR-T cell functionality in a patient-specific manner.		2023
34807983	GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial.	Blood Adv	2022
36112691	Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy.	Science advances	2022
35914154	Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.	Proceedings of the National Academy of Sciences of the United States of America	2022
35775490	Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma.	J Clin Invest	2022
36107461	AML relapse after a TIGIT race.	Blood	2022
36097221	Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma.	Nat Med	2022
35835100	Cancer vaccines: Building a bridge over troubled waters.	Cell	2022
36228153	Vaccination with Designed Neopeptides Induces Intratumoral, Cross-reactive CD4+ T-cell Responses in Glioblastoma.	Clin Cancer Res	2022
35508657	Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanoma.	Nature	2022
35443043	Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer.	Clinical Cancer Research	2022
35442713	Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A).	Journal of Clinical Oncology	2022
36223726	Spatial maps of TÂ cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response.	Immunity	2022
36001803	Genomic profiling for clinical decision making in lymphoid neoplasms.	Blood	2022
35429774	Editorial overview: Vaccines: Reinvigorating therapeutic cancer vaccines.		2022
35802667	Transcriptomic Correlates of Tumor Cell PD-L1 Expression and Response to Nivolumab Monotherapy in Metastatic Clear Cell Renal Cell Carcinoma.	Clin Cancer Res	2022